glp-1 medications approved for diabetes and weight loss 2025 Drugs: How Semaglutide & Tirzepatide Redefine Obesity Care GLP-1: A Breakthrough in Diabetes

Future studies should investigate whether these findings may be replicated in larger and more diverse study samples

Indeed GLP-1R agonists proved to be efficient for the treatment of type 2 diabetes mellitus 37 and studies indicate they could be used in other indications 26,43,44 such as obesity 45,46 , adverse cardiovascular events 25 , cognitive disorders 44 and non-alcoholic steatohepatitis (NASH) 47

While many studies focus on germline-less glp-1(e2144) mutants, the hermaphroditic germline of C

While semaglutide does not have direct CNS stimulant effects, some patients report fatigue or mood alterations

& Lund, B